Antipsychotic and benzodiazepine use among nursing home residents: Findings from the 2004 national nursing home survey

American Journal of Geriatric Psychiatry

Volumn 18, Issue 12, 2010, Pages 1078-1092

  Stevenson, David G ^a   Decker, Sandra L ^b   Dwyer, Lisa L ^b   Huskamp, Haiden A ^a   Grabowski, David C ^a   Metzger, Eran D ^c,d   Mitchell, Susan L ^c,e  

^a HARVARD MEDICAL SCHOOL   (United States)

^b NATIONAL CENTER FOR HEALTH STATISTICS   (United States)

^c Hebrew Senior Life   (United States)

^d Departments of Psychiatry   (United States)

^e BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

antipsychotics; benzodiazepines; Nursing homes

Indexed keywords

BENZODIAZEPINE; NEUROLEPTIC AGENT;

ADULT; AGED; ARTICLE; BEHAVIOR DISORDER; DRUG USE; FEMALE; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICARE; NURSING HOME; RESIDENT;

EID: 79751525724     PISSN: 10647481     EISSN: 15457214     Source Type: Journal    
DOI: 10.1097/JGP.0b013e3181d6c0c6     Document Type: Article

References (41)

1. Avorn J, Gurwitz JH: Drug use in the nursing home. Ann Intern Med 1995; 123:195-204
2. The Lewin Group: Review of Current Standards of Practice for Long-Term Care Pharmacy Services: Long-Term Care Pharmacy Primer. Baltimore, US Centers for Medicare and Medicaid Services 2004
3. Stuart B, Simoni-Wastila L, Baysac F, et al: Coverage and use of prescription drugs in nursing homes: implications for the medicare modernization act. Med Care 2006; 44:243-249 (Pubitemid 43755451)
4. Institute of Medicine (U.S.): Committee on Nursing Home Regulation: Improving the Quality of Care in Nursing Homes. Washington, DC, National Academy Press, 1986
5. Gurwitz JH, Field TS, Avorn J, et al: Incidence and preventability of adverse drug events in nursing homes. Am J Med 2000; 109: 87-94
6. U.S. Office of the Inspector General: Prescription Drug Use in Nursing Homes. Washington, DC, U.S. Department of Health and Human Services, 1997
7. Briesacher BA, Limcangco MR, Simoni-Wastila L, et al: The quality of antipsychotic drug prescribing in nursing homes. Arch Intern Med 2005; 165:1280-1285 (Pubitemid 40989593)
8. Gurwitz JH, Field TS, Judge J, et al: The incidence of adverse drug events in two large academic long-term care facilities. Am J Med 2005; 118:251-258 (Pubitemid 40312636)
9. Mendelson D, Rajeev R, Abramson R, et al: Prescription Drugs in Nursing Homes: Managing Costs in a Complex Environment. Washington, DC, George Washington University, 2002
10. Kuehn BM: FDA: antipsychotics risky for elderly. JAMA 2008; 300:379-380
11. Wang PS, Bohn RL, Glynn RJ, et al: Hazardous benzodiazepine regimens in the elderly: effects of half-life, dosage, and duration on risk of hip fracture. Am J Psychiatry 2001; 158: 892-898 (Pubitemid 32547618)
12. Passmore MJ, Gardner DM, Polak Y, et al: Alternatives to atypical antipsychotics for the management of dementia-related agitation. Drugs Aging 2008; 25:381-398 (Pubitemid 351629665)
13. Mantone J: Antipsychotic drugs abused as chemical restraints for elderly, [Electronic version]. Wall Street Journal Health Blog. Available at: http://blogs.wsj.com/health/2007/12/04/antipsychotic-drugs-abused-as-chemical- restraints-for-elderly/. Accessed March 6, 2009
14. Svarstad BL, Mount JK: Effects of residents' depression, sleep, and demand for medication on benzodiazepine use in nursing homes. Psychiatr Serv 2002; 53:1159-1165 (Pubitemid 34976629)
15. Simoni-Wastila L, Ryder PT, Qian J, et al: Association of antipsy-chotic use with hospital events and mortality among medicare beneficiaries residing in long-term care facilities. Am J Geriatr Psychiatry 2009; 17:417-427
16. Rochon PA, Normand SL, Gomes T, et al: Antipsychotic therapy and short-term serious events in older adults with dementia. Arch Intern Med 2008; 168:1090-1096 (Pubitemid 351749226)
17. Buffett-Jerrott SE, Stewart SH: Cognitive and sedative effects of benzodiazepine use. Curr Pharm Des 2002; 8: 45-58 (Pubitemid 34449902)
18. Ray WA, Thapa PB, Gideon P: Benzodiazepines and the risk of falling in nursing home residents. J Am Geriatr Soc 2000; 48: 682-685 (Pubitemid 30390461)
19. Fick DM, Cooper JW, Wade WE, et al: Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch Intern Med 2003; 163:2716-2724 (Pubitemid 37517412)
20. Alexopoulos GS, Streim J, Carpenter D, et al: Using antipsychotic agents in older patients. J Clin Psychiatry 2004; 65(suppl 2):5-99; discussion 100-102; quiz 103-104
21. Longo LP, Johnson B: Addiction: part I. Benzodiazepines-side effects, abuse risk and alternatives. Am Fam Physician 2000; 61:2121-2128 (Pubitemid 30225617)
22. Gill SS, Bronskill SE, Normand SL, et al: Antipsychotic drug use and mortality in older adults with dementia. Ann Intern Med 2007; 146:775-786 (Pubitemid 351650498)
23. Wu CS, Wang SC, Chang IS, et al: The association between dementia and long-term use of benzodiazepine in the elderly: nested case-control study using claims data. Am J Geriatr Psychiatry 2009; 17:614-620
24. Chang CM, Wu EC, Chang IS, et al: Benzodiazepine and risk of hip fractures in older people: a nested case-control study in Taiwan. Am J Geriatr Psychiatry 2008; 16:686-692
25. Gurvich T, Cunningham JA: Appropriate use of psychotropic drugs in nursing homes. Am Fam Physician 2000; 61:1437-1446 (Pubitemid 30155372)
26. Hughes CM, Lapane KL, Mor V: Influence of facility characteristics on use of antipsychotic medications in nursing homes. Med Care 2000; 38:1164-1173
27. Liperoti R, Mor V, Lapane KL, et al: The use of atypical antipsy-chotics in nursing homes. J Clin Psychiatry 2003; 64:1106-1112 (Pubitemid 37158258)
28. Svarstad BL, Mount JK: Chronic benzodiazepine use in nursing homes: effects of federal guidelines, resident mix, and nurse staffing. J Am Geriatr Soc 2001; 49:1673-1678 (Pubitemid 34007995)
29. U.S. Centers for Medicare and Medicaid Services: State Operations Manual, Appendix pp-Guidance to Surveyors for Long
30. Term Care Facilities. Available at: http://cms.hhs.gov/manuals/Downloads/ som107apppguidelinesltcf.pdf. Assessed March 1, 2009
31. Curtin F, Schulz P: Clonazepam and lorazepam in acute mania: a Bayesian meta-analysis. J Affect Disord 2004; 78:201-208 (Pubitemid 38167738)
32. Mor V, Berg K, Angelelli J, et al: The quality of quality measurement in U.S. nursing homes. Gerontologist 2003; 43(Spec No. 2): 37-46 (Pubitemid 41185032)
33. U.S. Centers for Medicare and Medicaid Services: Medicare Coverage of Skilled Nursing Facility Care. Available at: http://www.medicare.gov/ publications/pubs/pdf/10153.pdf Accessed December 15, 2008
34. US Census: Metropolitan and Micropolitan Statistical Areas. Washington, DC, US Census, 2008
35. Levy PS, Lemeshow S: Sampling of Populations. New York, Wiley, 1999
36. Williams RL: A note on robust variance estimation for cluster-correlated data. Biometrics 2000; 56:645-646 (Pubitemid 30422662)
37. StataCorp: Stata Statistical Software: Release 10. College Station, TX, StataCorp LP, 2007
38. Institute of Medicine (U.S.): Committee on improving quality in long-term care, in Improving the Quality of Long-Term Care. Edited by Wunderlich GS, Kohler PO. Washington, DC, National Academy Press, 2001
39. Nishtala PS, McLachlan AJ, Bell JS, et al: Psychotropic prescribing in long-term care facilities: impact of medication reviews and educational interventions. Am J Geriatr Psychiatry 2008; 16: 621-632
40. Schneider LS, Tariot PN, Dagerman KS, et al: Effectiveness of atypical antipsychotic drugs in patients with Alzheimer's disease. N Engl J Med 2006; 355:1525-1538 (Pubitemid 44547805)
41. Sultzer DL, Davis SM, Tariot PN, et al: Clinical symptom responses to atypical antipsychotic medications in Alzheimer's disease: phase 1 outcomes from the CATIE-AD effectiveness trial. Am J Psychiatry 2008; 165:844-854 (Pubitemid 351948716)